A tragic triad: coronary artery disease, nicotine addiction, and depression

Anne N Thorndike1, Nancy A Rigotti

  • 1General Medicine Division, Tobacco Research and Treatment Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. athorndike@partners.org

Insights

Smokers with cardiovascular disease (CVD) who are depressed are more likely to resume smoking after hospitalization. Intensive, long-term counseling and pharmacotherapy are recommended for smoking cessation in this population.

Area of Science:

  • Cardiology
  • Psychiatry
  • Public Health

Background:

  • Continued smoking significantly increases risks for patients with cardiovascular disease (CVD).
  • Depression is prevalent in CVD patients and linked to poor adherence to cardiac risk reduction strategies.
  • Most smokers with CVD resume smoking post-hospitalization despite available treatments.

Purpose of the Study:

  • To review the intricate relationship between smoking and depression in cardiovascular disease (CVD) patients.
  • To examine current evidence for interventions targeting this triad of smoking, depression, and CVD.
  • To identify effective strategies for smoking cessation in hospitalized CVD patients with depressive symptoms.

Main Methods:

  • Systematic review of smoking interventions in hospitalized patients.
  • Analysis of secondary data on treatment efficacy for smokers with depression and CVD.
  • Literature review on the association between depressive symptoms and smoking relapse in CVD patients.

Main Results:

  • Depressive symptoms affect 22-24% of smokers hospitalized with CVD.
  • Smokers with depression experience more intense nicotine withdrawal and higher relapse rates.
  • Intensive counseling exceeding one month and potentially bupropion SR or CBT show promise for cessation.

Conclusions:

  • Screening for depression in CVD smokers, especially during acute events, is crucial.
  • Hospitalized CVD smokers require extended (>1 month) intensive counseling for cessation.
  • Prolonged treatment, possibly including pharmacotherapy, is needed for depressed CVD smokers to quit smoking.
Abstract

Related Concept Videos

CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants


Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Stress Prevention and Stress Management Techniques IV01:26

Stress Prevention and Stress Management Techniques IV

Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
Drug Dependence01:17

Drug Dependence

Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...